RxDoctor Payments Data

Angela Thornton, NP

Family · Athens, GANPI 1659741510

Payments from drug & device makers

$562in general payments, 2019–2025

Across 31 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$82
  • Lilly USA, LLC$78
  • AstraZeneca$68
  • Dexcom, Inc.$64
  • Exact Sciences$41
  • Abbott$38
  • plus $192 from 10 others

What the payments were for

  • Food & beverage$53896%
  • Other$254%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$562 in reported general payments places this provider in the 55th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$750
Medicare patients
19
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$87,809
TrulicityDulaglutide33$80,022
FarxigaDapagliflozin Propanediol45$53,399
MounjaroTirzepatide27$42,253
LinzessLinaclotide31$33,767
JanuviaSitagliptin Phosphate29$32,215
JanumetSitagliptin Phos/Metformin Hcl27$25,154
Janumet XrSitagliptin Phos/Metformin Hcl13$16,744
Diclofenac Sodium14$16,255
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$16,239
Tresiba Flextouch U-100Insulin Degludec17$15,146
EliquisApixaban14$11,950
TradjentaLinagliptin11$9,527
Humalog Kwikpen U-100Insulin Lispro18$8,853
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$78$122,27560 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$68$74,20171 claims
MerckJanuvia, Janumet, Janumet Xr$11$74,11269 claims
PfizerEliquis$16$11,95014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,258 family providers in Georgia.

Other family in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →